If you have looked into joining a clinical trial, you have probably come across the terms "Phase 2" and "Phase 3" and wondered what they actually mean for you as a patient. Trial phases can sound like technical regulatory jargon, but understanding them can make the decision to participate feel far less uncertain. This guide breaks down what each phase of a clinical trial involves, why the phase system exists, and where the studies currently underway at Lung Research Florida fit into that process.

Every clinical trial conducted at our Plantation, FL facility, led by Dr. Frank Hull, follows the same phased research structure used across the pharmaceutical and biotechnology industry and required by the U.S. Food and Drug Administration (FDA). Knowing how this system works can help you ask better questions and feel more confident about whatever decision you make regarding research participation.

Why Clinical Trials Are Divided Into Phases

Before any investigational medication reaches the point of being studied in patients with a specific condition, it typically has years of laboratory and animal research behind it. Human clinical trials then proceed in a stepwise fashion, with each phase designed to answer a different question. This phased approach exists to protect participant safety — researchers build on what was learned in the previous phase before expanding the number of people exposed to an investigational treatment.

Phase 1: Is It Safe, and What Dose?

Phase 1 trials are usually the first time an investigational treatment is tested in humans. These studies typically involve a small number of participants, often healthy volunteers, and focus almost entirely on safety, tolerability, and identifying an appropriate dose range. Lung Research Florida does not typically conduct Phase 1 studies; our research is generally focused on later-phase trials.

Phase 2: Does It Work, and at What Dose?

Phase 2 trials enroll a larger group of participants, usually people who actually have the condition being studied, such as severe asthma, COPD, chronic cough, or bronchiectasis. These studies begin to evaluate whether the treatment appears to be effective, refine the dose further, and continue close monitoring for side effects. Phase 2 studies are still relatively contained, often involving several dozen to a few hundred participants across multiple research sites.

Phase 3: Confirming Effectiveness and Safety

Phase 3 trials are larger still, sometimes involving hundreds or thousands of participants across many research sites nationally or internationally. The goal is to confirm effectiveness in a broader, more diverse population, compare the investigational treatment against a placebo or existing standard-of-care therapy, and continue to monitor for less common side effects that may not have appeared in smaller earlier-phase studies. Data from successful Phase 3 trials is generally what a pharmaceutical company submits to the FDA when seeking approval of a new treatment.

Phase 4: Monitoring After Approval

Phase 4 studies, also called post-marketing studies, take place after a treatment has already received FDA approval and is available to the public. These studies continue to track long-term safety and effectiveness in real-world use, sometimes in larger or more varied patient populations than earlier phases allowed.

What Phase Are Lung Research Florida's Studies?

Respiratory research conducted at Lung Research Florida is generally in Phase 2 or Phase 3, meaning the investigational treatments being studied have already progressed past initial human safety testing. For example, our IMAGINE Study for severe eosinophilic asthma is a Phase 3b research program. Studies for COPD, chronic cough, and bronchiectasis similarly tend to fall within the Phase 2 to Phase 3 range, though the exact phase and design of any specific study can change as trials open, close, or move into new stages of enrollment. Because of this, our research coordinators will always confirm the current phase and design of any study you are considering, before you make any decision about participating.

Being further along in the phase sequence does not remove the need for careful safety monitoring, and it does not guarantee that an investigational treatment will ultimately be approved or will work for every participant. What it does mean is that a treatment has already passed through earlier stages of human testing before reaching the study you may be considering.

How Understanding Phases Can Help You Decide

Many patients feel more comfortable moving forward once they understand where a study sits in the overall research process. Knowing whether a trial is Phase 2 or Phase 3 can help you understand roughly how many other participants have been involved in similar research, what kind of comparison group the study may use, and what questions to ask during informed consent. If you are new to clinical research generally, our step-by-step guide to what to expect when you join a trial walks through the full process from first contact to study completion.

Frequently Asked Questions

What is the difference between a Phase 2 and Phase 3 clinical trial?

Phase 2 trials involve a smaller group of participants and focus on dose and an early signal of effectiveness. Phase 3 trials enroll larger, more diverse groups to confirm effectiveness and further evaluate safety, often comparing the treatment to a placebo or standard-of-care therapy.

Is a Phase 3 trial safer than a Phase 2 trial?

By Phase 3, more safety data has typically been gathered than in earlier phases, but no phase eliminates risk entirely. Every phase includes close, ongoing safety monitoring, and your care team will review the specific safety information for any study you are considering.

Will I be told what phase a study is in before I decide to join?

Yes. The phase, purpose, and design of a study are explained during informed consent before you agree to participate, and you are encouraged to ask questions about what the phase means for your situation.

Does the trial phase affect whether I might receive a placebo?

It can, but it depends on the specific study design rather than the phase alone. Your research coordinator will explain a study's design, including whether a placebo is used, before you decide whether to enroll.

For broader questions about trial safety, compensation, and confidentiality, visit our full Clinical Trials FAQ.

Clinical trial participation is voluntary. All studies are reviewed and approved by an independent Institutional Review Board (IRB) and follow FDA safety guidelines regardless of phase. This page is for informational purposes and does not constitute medical advice. Please consult your physician to determine whether a clinical trial may be appropriate for your individual situation.